Smoke Evacuation System Market 2019 | Growth Opportunities | Global Analysis 2024

Smoke Evacuation System Market by Product (Smoke Evacuator (Portable & Stationary), Filter, Pencil, Accessories), Application (General Surgery, Laparoscopic, Orthopedic, Aesthetic), End-User (Hospitals, ASC, Surgical Centers) - Global Forecast to 2024

(EMAILWIRE.COM, May 31, 2019 ) The smoke evacuation systems market is estimated to grow at a CAGR of 6.6% to reach USD 223 million by 2024 from USD 162 million in 2019.

Factors such increased product availability of smoke evacuation systems, rising patient preference for minimally invasive surgeries, expansion in the target patient population, and wider acceptance and availability of relevant operating room protocols and guidelines for smoke evacuation systems are the major factors driving the growth of the global smoke evacuation system market.

Download FREE Brochure @ https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=149736406

Key Market Players
CONMED Corporation (US), Medtronic Plc (Ireland), Olympus (Japan), Ethicon (US), Erbe Elektromedizin GmbH (Germany), KLS Martin (Germany), Stryker Corporation (US), I.C Medical (US), Symmetry Surgical Inc. (US), Utah Medical Products Inc (US), Zimmer Biomet (US), Pall Corporation (US), Ecolab (US), and Deroyal (US) are some of the major players in the global smoke evacuation system market.

Recent Developments
In November 2019, CONMED Corporation (US) acquired Buffalo Filter LLC (US) in order to improve its smoke evacuation product line.

In January 2018, Stryker Corporation (US) acquired Safe Air (Switzerland) to enhance its product portfolio in surgical smoke evacuation.

In January 2017, Ethicon (US) acquired Megadyne Medical Products (US), Inc. to expand its advanced energy portfolio related to smoke evacuation products.

Request for Sample @ https://www.marketsandmarkets.com/requestsampleNew.asp?id=149736406

This report covers the smoke evacuation systems market across four major geographies North America, Europe, Asia Pacific, and the Rest of the World. North America commanded the largest share of the market mainly due to factors such as the increase in the number of inpatient surgeries performed in the US, expansion in the target disease population, and wider acceptance and availability of relevant protocols and guidelines in the North America region.